"Single pill combining five heart drugs appears safe"
Source: CTV.CA
Published: 30 Mar 2022
Category: Pharmaceutical
Rating:
(1 star)
what they said (Hover the mouse cursor over underlined words for more info)
Imagine if people at risk of heart disease could take a single pill that would contain all the medications they need to reduce their heart risk. Such a pill is already a reality and now new research suggests it's safe and effective.
It's called a polypill and could soon become a cheap, simple way to prevent both heart disease and stroke...
The original article can be found at: http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20090330/polypill_090330/20090330?hub=TopStories
Criteria |
Rating |
Availability of Treatment |
Not Satisfactory (?) |
Novelty of Treatment |
Not Satisfactory (?) |
Disease Mongering |
Satisfactory (?) |
Treatment Options |
Satisfactory (?) |
Costs of Treatment |
Not Satisfactory (?) |
Evidence |
Not Satisfactory (?) |
Quantification of Benefits of Treatment |
Not Satisfactory (?) |
Harms of Treatment |
Not Satisfactory (?) |
Sources of Information |
Not Satisfactory (?) |
Relies on Press Release |
Not Applicable |
Quantification of Harms of Treatment |
Not Satisfactory (?) |
what we said (Hover the mouse cursor over underlined words for more info)
This story delivers a hyped conclusion on the basis of very poor evidence. While the report characterized the drug as a "lifesaver", the evidence to support this claim was presented in relative values and only related to surrogate markers as opposed to clinical markers (such as effects on heart attach or stroke). The readers comments following the article give some insight into its impact, with people clamoring for such a pill. It would have been helpful for the author to comment on the polypill availability and heavily emphasize that it is still in the preliminary research phase.
The article provided little information on the study design. Accessing the published paper and study results reveals that it was a double-blind study which only followed patients for 12-weeks. The shortness of the trials warrants a more extensive discussion of the limitations of the research findings. One would have to ask if it is premature to say the drug is "safe and effective" especially if taken over years and years? The entire concept of mixing different compounds into one pill is very poor medicine. It doesn't permit physicians to customize the dose for specific patients depending on the patient's specific risk factors. Without any data on the impact of real and non-anecdotal outcomes (like rates of heart attack and stroke) patients should be cautious when considering the use of this polypill- that is, of course assuming it will hit the Canadian market.
public forum
|